Correlation Between MEDIANA CoLtd and AptaBio Therapeutics
Can any of the company-specific risk be diversified away by investing in both MEDIANA CoLtd and AptaBio Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MEDIANA CoLtd and AptaBio Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MEDIANA CoLtd and AptaBio Therapeutics, you can compare the effects of market volatilities on MEDIANA CoLtd and AptaBio Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MEDIANA CoLtd with a short position of AptaBio Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of MEDIANA CoLtd and AptaBio Therapeutics.
Diversification Opportunities for MEDIANA CoLtd and AptaBio Therapeutics
0.42 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between MEDIANA and AptaBio is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding MEDIANA CoLtd and AptaBio Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AptaBio Therapeutics and MEDIANA CoLtd is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MEDIANA CoLtd are associated (or correlated) with AptaBio Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AptaBio Therapeutics has no effect on the direction of MEDIANA CoLtd i.e., MEDIANA CoLtd and AptaBio Therapeutics go up and down completely randomly.
Pair Corralation between MEDIANA CoLtd and AptaBio Therapeutics
Assuming the 90 days trading horizon MEDIANA CoLtd is expected to under-perform the AptaBio Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, MEDIANA CoLtd is 2.01 times less risky than AptaBio Therapeutics. The stock trades about -0.04 of its potential returns per unit of risk. The AptaBio Therapeutics is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 797,000 in AptaBio Therapeutics on September 2, 2024 and sell it today you would lose (145,000) from holding AptaBio Therapeutics or give up 18.19% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
MEDIANA CoLtd vs. AptaBio Therapeutics
Performance |
| Timeline |
| MEDIANA CoLtd |
| AptaBio Therapeutics |
MEDIANA CoLtd and AptaBio Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with MEDIANA CoLtd and AptaBio Therapeutics
The main advantage of trading using opposite MEDIANA CoLtd and AptaBio Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MEDIANA CoLtd position performs unexpectedly, AptaBio Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AptaBio Therapeutics will offset losses from the drop in AptaBio Therapeutics' long position.| MEDIANA CoLtd vs. AptaBio Therapeutics | MEDIANA CoLtd vs. KT Hitel | MEDIANA CoLtd vs. SillaJen | MEDIANA CoLtd vs. Cytogen |
| AptaBio Therapeutics vs. ABL Bio | AptaBio Therapeutics vs. Helixmith Co | AptaBio Therapeutics vs. OliX PharmaceuticalsInc | AptaBio Therapeutics vs. Oscotec |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |